Guidlines for the good laboratory practice in assisted reproduction – clean environment

Czech version

Authors: P. Trávník ¹; R. Hűttelová ²; L. Jelínková ³; A. Malenovská ⁴; Tonko Mardešič ³; E. Oráčová ¹; J. Žáková ⁵
Authors‘ workplace: REPROMEDA s. r. o., Brno, ředitelka MUDr. K. Veselá, Ph. D. ¹; IVF Cube SE, Praha, vedoucí lékařka, MUDr. H. Višňová, Ph. D. ²; PRONATAL, s. r. o., Praha, vedoucí lékař doc. MUDr. T. Mardešič, CSc. ³; Reprofit International, s. r. o., Brno, vedoucí MUDr. M. Koudelka ⁴; Gynekologicko-porodnická klinika LF MU a FN, Brno, přednosta prof. MUDr. P. Ventruba, DrSc., MBA ⁵
Published in: Ceska Gynekol 2014; 79(2): 156-162

Overview

The guidlines are the recommendation for good laboratory practice in embryological laboratories. In this first part the requirements of the clean environment from the point of view of the oocytes, sperm, and embryos protection against infection and from point of view of the embryological laboratory staff health protection were described.

Keywords:
guidlines, good laboratory practice, clinical embryology, embryological laboratory

Sources

1. Ben-Chetrit, A., Shen, O., Haran, E., et al. Transfer of embryos from yeast-colonized dishes. Fertil Steril, 1996, 66, p. 335–337.

2. Bennett, SJ., Waterstone, JJ., Cheng, WC., Parsons, J. Complications of transvaginal ultrasound-directed follicle aspiration: a review of 2670 consecutive procedures. J Assist Reprod Genet, 1993, 10, p. 72–77.

3. Bergh, T., Lundkvist, Ö. Clinical complications during in-vitro fertilization treatment. Hum Reprod, 1992, 7, p. 625–626.

4. Boitrelle, F., Robin, G., Lefebvre, C., et al. Bacteriospermia in Assisted Reproductive Techniques: effects of bacteria on spermatozoa and seminal plasma, diagnosis and treatment. Gynecol Obstet Fertil, 2012, 40(4), p. 226-234. Epub 2012 Mar 3.

5. Clarke, GN. Sperm cryopreservation: is there a significant risk of crosscontamination? Hum Reprod, 1999, 14(12), p. 2941–2943.

6. Cobo, A., Bellver, J., de los Santos, MJ., Remohí, J. Viral screening of spent culture media and liquid nitrogen samples of oocytes and embryos from hepatitis B, hepatitis C, and human immunodeficiency virus chronically infected women undergoing in vitro fertilization cycles. Fertil Steril, 2012, 97(1), p. 74–78. doi: 10.1016/j.fertnstert.2011.10.006. Epub 2011 Oct 26.

7. Cottell, E., Lennon, B., McMorrow, J., et al. Processing of semen in an antibiotic-rich medium to minimize microbial presence during in vitro fertilization. Fertil Steril, 1997, 67, p. 98–103.

8. Cottell, E., McMorrow, J., Lennon, B., et al. Microbial contamination in an in vitro fertilization - embryo transfer system. Fertil Steril, 1996, 66, p. 776–780.

9. Devaux, A., Soula, V., Sifer, C., et al. Hepatitis C virus detection in follicular fluid and culture media from HCV+ women, and viral risk during IVF procedures. Human Reprod, 2003, 18(11), p. 2342–2349.

10. Domes, T., Lo, KC., Grober, ED., et al. The incidence and effect of bacteriospermia and elevated seminal leukocytes on semen parameters. Fertil Steril, 2012, 97(5), p. 1050–1055. Epub 2012 Feb 16.

11. Englert, Y., Lesage, B., Van Vooren, J-P., et al. Medically assisted reproduction in the presence of chronic viral diseases. Human Reprod Update, 2004, 10(2), p. 149–162.

12. EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use, Annex 1 - Manufacture of Sterile Medicinal Products (corrected version), 2008.

13. Garrido, N., Bellver, J., Rubio, C., Pellicer, A. Hepatitis B virus in human oocytes and embryos. Comment on The presence and expression of the hepatitis B virus in human oocytes and embryos. [Hum Reprod. 2011]. Hum Reprod. 2012, 27(4), p. 1227–1228, author reply 1228–1229. doi: 10.1093/humrep/des024. Epub 2012 Feb 14.

14. Hu, XL., Zhou, XP., Qian, YL., et al. The presence and expression of the hepatitis B virus in human oocytes and embryos. Hum Reprod, 2011, 26(7), p. 1860–1867. doi: 10.1093/humrep/der103. Epub 2011 Apr 12.

15. Kastrop, PM., de Graaf-Miltenburg, LA., Gutknecht, DR., Weima, SM. Microbial contamination of embryo cultures in an ART laboratory: sources and management. Hum Reprod, 2007, 22(8), p. 2243–2248.

16. Kawana, R., Kitamura, T., Nakagomi, O., et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology, 1997, 195, Suppl. 2, p. 29–35.

17. Klemetti, R., Sevón, T., Gissler, M., Hemminki, E. Compli-cations of IVF and ovulation induction. Hum Reprod, 2005, 20, p. 3293–3300.

18. Kunisada, T., Yamada, K., Oda, S., Hara, O. Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology. 1997, 195, Suppl. 2, p. 14–18.

19. Mali, MC., Van den Abbeel, E., Lundin, K., et al. Revised guidelines for good practice in IVF laboratories. Hum Reprod, 2008, 23(6), p. 1253–1262.

20. Matsunaga, Y., Fukushima, K., Nozaki, M., et al. A case of pregnancy complicated by the development of a tubo-ovarian abscess following in vitro fertilization and embryo transfer. Am J Perinatol, 2003, 20, p. 277–282.

21. Mohd Hanafiah, K., Groeger, J., Flaxman, AD., Wier-sma, ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology, 2013, 57(4), p. 1333–1342. doi: 10.1002/hep.26141. Epub 2013 Feb 4.

22. Morison, L. The global epidemiology of HIV/AIDS. Brit Med Bull, 2001, 58(1), p. 7–18.

23. Nie, R., Jin, L., Zhang, H., et al. Presence of hepatitis B virus in oocytes and embryos: a risk of hepatitis B virus transmission during in vitro fertilization. Fertil Steril, 2011, 95(5), p. 1667–1671. doi: 10.1016/j.fertnstert.2010.12.043. Epub 2011 Jan 26.

24. Nyboe Andersen, A., Gianaroli, L., Felderbaum, R., et al. Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod, 2005, 20, p. 1158–1176.

25. Obłąk, E., Gamian, A. The biological activity of quaternary ammonium salts (QASs). Postepy Hig Med Dosw (online), 2010, 64, p. 201–211.

26. Papaxanthos-Roche, A., Trimoulet, P., Commenges-Ducos, M., et al. PCR-detected hepatitis C virus RNA associated with human zona-intact oocytes collected from infected women for ART. Hum Reprod, 2004, 19(5), p. 1170–1175.

27. Proietti, FA., Carneiro-Proietti, AB., Catalan-Soares, BC., Murphy, EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene, 2005, 24(39), p. 6058–6068.

28. Selman, H., Mariani, M., Barnocchi, N., et al. Examination of bacterial contamination at the time of embryo transfer, and its impact on the IVF/pregnancy outcome. J Assist Reprod Genet, 2007, 24(9), p. 395–399. Epub 2007 Jul 17.

29. Sharpe, K., Karovitch, AJ., Claman, P., Suh, KN. Transvaginal oocyte retrieval for in vitro fertilization complicated by ovarian abscess during pregnancy. Fertil Steril, 2006, 86, p. 219.e11–3.

30. Teo, EK., Lok, ASF. Epidemiology, transmission, and prevention of hepatitis B virus infection. UpToDate, 2013. Release: 21.8 - C21.112, UpToDate, Inc.

31. Tsai, YC., Lin, MY., Chen, SH., et al. Vaginal disinfection with povidone iodine immediately before oocyte retrieval is effective in preventing pelvic abscess formation without compromising the outcome of IVF-ET. J Assist Reprod Genet, 2005, 22, p. 173–175.

32. Vyhláška 537/2006 Sb. o očkování proti infekčním nemocem ve znění pozdějších předpisů (novelizovaná vyhláškou 299/2010 Sb.)

33. Vyhláška č. 422/2008 Sb. o stanovení bližších požadavků pro zajištení jakosti a bezpečnosti lidských tkání a buněk určených k použití u člověka novelizovaná vyhláškou č. 339/2012 Sb.

34. Wingfield, M., Cottell, E. Viral screening of couples undergoing partner donation in assisted reproduction with regard to EU Directives 2004/23/EC, 2006/17/EC and 2006/86/EC: what is the evidence for repeated screening? Hum Reprod, 2010, 25(12), p. 3058–3065. Advanced Access publication on October 17, 2010 doi:10.1093/humrep/deq261

35. Wood, A., Payne, D. The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses. J Hosp Infect, 1998, 38(4), p. 283–289.

36. Wright, DJ., Norris, SJ., Dhillon, RHP., Edmondson, DG. Syphilis: Epidemiological Aspects. John Wiley & Sons Ltd. Published Online: 15 JAN 2012. DOI: 10.1002/9780470015902.a0023926

37. Zákon č. 258/2000 Sb. o ochraně veřejného zdraví a o změně některých souvisejících zákonů, ve znění pozdějších předpisů.